Llwytho...
Targeting protein-protein interactions in hematologic malignancies: still a challenge or a great opportunity for future therapies?
Over the past several years, there has been an increasing research effort focused on inhibition of protein-protein interactions (PPIs) to develop novel therapeutic approaches for cancer, including hematologic malignancies. These efforts have led to development of small molecule inhibitors of PPIs, s...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Immunol Rev |
|---|---|
| Prif Awduron: | , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
2015
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4457300/ https://ncbi.nlm.nih.gov/pubmed/25510283 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/imr.12244 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|